Navigation Links
Verenium Corporation to Announce Third Quarter 2008 Financial Results
Date:11/3/2008

CAMBRIDGE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it will release third quarter 2008 financial results on Monday, November 10, 2008 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Monday, November 10 at 5:00 p.m. ET.

The call may be accessed by dialing 866-831-6224 (domestic) or 617-213-8853 (international) five minutes prior to start time and providing the passcode 98577379. A link to the live webcast may be accessed by visiting the "Investors" section of the Company's website at http://www.verenium.com. A replay of the event will be available on the Company's website approximately two hours after the call and will be archived for 30 days.

About Verenium

Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and health and nutrition markets. The Company possesses integrated, end-to-end capabilities in pre-treatment, novel enzyme development, fermentation, engineering, and project development and is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products
'/>"/>

SOURCE Verenium Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
2. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
3. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
4. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
5. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
6. Verenium Reports Financial Results for the First Quarter 2008
7. Verenium Appoints John F. Dee to Board of Directors
8. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
9. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
10. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 277 percent of European pigs are castrated without anesthetic 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 3Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 1Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 2Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 3Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 4Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 5Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 6Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 7Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 8Misonix Reports First Quarter Fiscal 2010 Financial Results 6297 9DAVISCO Foods International Inc and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose 6295 1DAVISCO Foods International Inc and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose 6295 2Childrens Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In Hospital Precinct 6293 1Childrens Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In Hospital Precinct 6293 2